Skip to main content
. 2021 Jun;173:306–330. doi: 10.1016/j.addr.2021.03.018

Fig. 1.

Fig. 1

An overview of pre-clinical breast cancer models, including in vitro 2D conventional culture systems, 3D culture systems, and in vivo models, indicating the related nanomedicine characterization assays afforded by their intrinsic characteristics and complexity.